BNTC
BNTC
NASDAQ · Biotechnology

Benitec Biopharma Inc

$13.63
+0.50 (+3.81%)
As of Aug 8, 10:23 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +97.1% upside
Low Target $21.20
Average Target $26.87
High Target $38.04
Current Price $13.63
Current
$13.63
Target
$26.87
$21.20 $26.87 avg $38.04
Scenario Analysis
Bear Case
$21.20
55.5%
Low target
Base Case
$26.87
+97.1%
Avg target
Bull Case
$38.04
+179.1%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$16.76
-18.7% from high
52-Week Low
$9.85
+38.4% from low
Target vs 52W High
$26.87
+60.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.0%